Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma cruzi | ion transport protein, putative | 0.0107 | 0.7209 | 0.5 |
Brugia malayi | Voltage-gated potassium channel, Shaker-family (KCNA, Kv1-like) alpha-subunit | 0.0092 | 0.5049 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0092 | 0.5049 | 0.5049 |
Loa Loa (eye worm) | hypothetical protein | 0.0063 | 0.0935 | 0.0935 |
Trypanosoma cruzi | ion transport protein, putative | 0.0107 | 0.7209 | 0.5 |
Echinococcus multilocularis | small conductance calcium activated potassium | 0.0126 | 1 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0126 | 1 | 1 |
Schistosoma mansoni | calcium-activated potassium channel | 0.012 | 0.9114 | 0.821 |
Schistosoma mansoni | calcium-activated potassium channel | 0.0126 | 1 | 1 |
Echinococcus multilocularis | potassium voltage gated channel protein | 0.0092 | 0.5049 | 0.1045 |
Leishmania major | ion transport protein-like protein | 0.0107 | 0.7209 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0126 | 1 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Inhibition (binding) | = 0 % | Inhibitory activity of compound against human cyclooxygeanse-2 expressed in sf-9 cells infected with baculovirus at 10 uM concentration | ChEMBL. | 14698190 |
Inhibition (binding) | = 0 % | Inhibitory activity of compound against human cyclooxygeanse-2 expressed in sf-9 cells infected with baculovirus at 10 uM concentration | ChEMBL. | 14698190 |
Inhibition (binding) | = 9 % | Inhibitory activity of compound against Prostaglandin G/H synthase 1 from ram seminal vesicles at 10 uM concentration | ChEMBL. | 14698190 |
Inhibition (binding) | = 9 % | Inhibitory activity of compound against Prostaglandin G/H synthase 1 from ram seminal vesicles at 10 uM concentration | ChEMBL. | 14698190 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.